pharmaphorum

OCTOBER 28, 2022

Although some life sciences companies are starting to shift to incorporate human-centered design practices, it is often coming late in the drug development process – well into the commercialisation efforts of launch planning, if not post-launch. gain insights to inform trial design and optimal target product profiles.

Life Science 105

Life Science Production Development Drugs 105

BioTech 365

FEBRUARY 23, 2021

ERS Genomics and G+FLAS Life Sciences sign CRISPR/Cas9 license agreement ERS Genomics and G+FLAS Life Sciences sign CRISPR/Cas9 license agreement G+FLAS Life Sciences is applying CRISPR technology to develop research tools and reagents DUBLIN & SEOUL–(BUSINESS WIRE)–ERS Genomics Limited, which … Continue reading →

Life Science 40

Life Science Genome Genomics Licensing 40

BioTech 365

NOVEMBER 16, 2020

Receptor Life Sciences Receives Schedule I Research License from U.S. Drug Enforcement Agency Receptor Life Sciences Receives Schedule I Research License from U.S. 16, 2020 (GLOBE NEWSWIRE) — Receptor Life Sciences announced today that the … Continue reading →

Life Science 40

Life Science Licensing Licensing Research 40

XTalks

FEBRUARY 4, 2025

Current Share Price: The announcement follows a $115 million Series D financing in December 2024, co-led by Frazier Life Sciences and Deep Track Capital, with participation from Janus Henderson Investors and Logos Capital. To further expand its research, Maze has entered several strategic partnerships and licensing agreements.

Clinical Trials 66

Clinical Trials Clinical Trials Trials Genetics 66

BioSpace

SEPTEMBER 8, 2021

Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses.

RNA 72

RNA Licensing Licensing Life Science 72

BioSpace

MARCH 14, 2021

Nearly five years to the day after striking the deal, AVEO Oncology and CANbridge Life Sciences announce the termination of their collaboration and licensing agreement for AVEO’s AV-203.

Life Science 86

Life Science Antibody Licensing Licensing 86

XTalks

FEBRUARY 5, 2025

Dr. Marcondes is a licensed and trained physician, specializing in oncology and immune oncology. Subscribe to the Xtalks Life Science Podcast to never miss a new episode. He has more than 15 years of research and teaching experience in Bone Marrow Transplant (BMT)/Cellular Therapies and more than 10 years of industry experience.

Clinical Development 59

Clinical Development Development Life Science Clinical Trials 59

BioTech 365

SEPTEMBER 1, 2021

Precision BioSciences and Tiziana Life Sciences Announce Exclusive License Agreement to Evaluate Foralumab, a Novel, Fully Human Anti-CD3 Monoclonal Antibody, in Conjunction with Allogeneic CAR T Candidates for Cancer Treatment Precision BioSciences and Tiziana Life Sciences Announce Exclusive License Agreement … Continue reading →

Life Science 40

Life Science Licensing Licensing Antibody 40

XTalks

AUGUST 10, 2022

In this episode, Ayesha discussed a new COVID-19 test technology that Innova Medical Group, world leader in at-home COVID-19 tests, has reached a licensing deal for with the University of Birmingham where the technology was developed. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 52

Life Science FDA Approval Drugs Licensing 52

XTalks

DECEMBER 4, 2024

These efforts aim to fast-track commercialization and out-licensing agreements in one of the world’s most promising pharmaceutical markets. International patents valid until 2036 further strengthen its global positioning.

Bioavailability 111

Bioavailability Genetic Disease Marketing RNA 111

XTalks

NOVEMBER 8, 2023

In this episode, Ayesha talked about the FDA’s acceptance of AstraZeneca’s supplemental biologics license application (sBLA) for a self-administered option of its nasal influenza vaccine FluMist Quadrivalent. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 52

Life Science Vaccination Vaccine Licensing 52

BioTech 365

AUGUST 17, 2020

SEOUL, South Korea & NANJING, China–(BUSINESS WIRE)–#NASH–LG Chem Life Sciences (“LG Chem”), a division of LG Chem, and TransThera Biosciences Co.

Life Science 40

Life Science Licensing Licensing 40

pharmaphorum

MARCH 16, 2021

Nuclear Regulatory Commission (NRC) has issued a Materials License for its new Indianapolis, IN headquarters. The license also expands SpectronRx’s roster of authorized nuclear pharmacists and authorized users. The license lists more than 25 different isotopes, ranging from Lutetium-177, Actinium-225, Iodine-131,and Iodine-123.

Licensing 52

Licensing Licensing Manufacturing Pharmacy 52

BioSpace

JANUARY 13, 2021

Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses.

Licensing 53

Licensing Licensing Life Science 53

STAT News

NOVEMBER 29, 2022

You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences.    Sign up to get this newsletter  delivered in your inbox every Tuesday and Thursday.

Life Science 98

Life Science Licensing Licensing Marketing 98

BioTech 365

SEPTEMBER 15, 2020

DOUGLAS, Isle of Man–(BUSINESS WIRE)–Juvenescence Limited (“Juvenescence”), a life sciences company focused on modifying aging and increasing human healthspan, announced today a partnership with Evgen Pharma plc to license its sulforaphane stabilization technology for use in several non-pharmaceutical applications led … (..)

Licensing 40

Licensing Licensing Life Science 40

FDA Law Blog

MAY 4, 2022

is pleased to announce that Sophia Gaulkin will be speaking on an expert panel at the 20th Advanced Summit on Life Sciences Patents , which is being held virtually and in-person in New York City on June 2-3, 2022. Hyman, Phelps & McNamara, P.C.

Life Science 40

Life Science Drugs Licensing Licensing 40

XTalks

JANUARY 26, 2022

A field application scientist is a valuable member of any life science company due to their direct interaction with customers. An application scientist typically works for life science companies that manufacture laboratory tools or provide a service for laboratory use. Field Scientist Job Description.

Scientist 98

Scientist Life Science Production Sales 98

XTalks

APRIL 1, 2025

It also plans to start discussions with the FDA regarding a potential Biologics License Application (BLA) submission. Equillium plans to submit the full results for presentation at an upcoming medical conference. This includes meeting requests to discuss the potential for Accelerated Approval, with feedback expected during May 2025.

Immune Response 94

Immune Response Trials Licensing Licensing 94

pharmaphorum

OCTOBER 12, 2022

Remaining compliant is imperative to the life sciences industry, so adhering to regulatory requirements is mandatory. The provision of these records must be readily available for auditing, and failing such regulatory audits can ultimately result in a license withdrawal. As the industry increases the adoption of Pharma 4.0,

Compliance 105

Compliance Manufacturing Life Science Production 105

XTalks

DECEMBER 18, 2024

In 2018, the company also received approval for Orilissa (elagolix), which it licenses to AbbVie, for the treatment of endometriosis. Neurocrines hit drug generated $613 million in sales during the third quarter and is projected to reach $2.3 billion in revenue by 2024.

Genetics 116

Genetics Hormones Trials Drugs 116

Pharmaceutical Technology

DECEMBER 14, 2022

Under the deal, Merck will license its VirusExpress 293 Adeno-Associated Virus (AAV) Production Platform. Merck and Synplogen have signed a non-binding Memorandum of Understanding (MoU) to expedite the development and manufacturing of viral vector-based gene therapy applications.

Gene Therapy 130

Gene Therapy Gene Development Manufacturing 130

pharmaphorum

DECEMBER 14, 2022

As many strive to bring about transformation in healthcare, Angelini Ventures takes a new approach to investments in digital health and life sciences companies that drive healthcare innovation and improve patient experiences. It aims to shape companies in the digital healthcare, connected medical devices, and life sciences spaces.

Life Science 105

Life Science Development Business Development Genetics 105

Drug Discovery Today

JANUARY 26, 2022

a leading provider of integrated drug discovery services to life science organisations globally, is delighted that Professors Daniel Longley, Tim Harrison and colleagues at Queen’s University Belfast have entered into a collaboration and licensing agreement with Ipsen. Saffron Walden, 26th January 2022 / Domainex Ltd.,

Licensing 40

Licensing Licensing Life Science Manufacturing 40

XTalks

JANUARY 22, 2025

IXCHIQ is the only licensed chikungunya vaccine in the US for adults aged 18 and older at increased risk of exposure to the virus. This includes post-marketing studies, label extensions for younger populations and a licensing agreement with the Serum Institute of India to supply the vaccine in Asia at affordable prices.

Immune Response 59

Immune Response Vaccination Vaccine Trials 59

Pharmaceutical Commerce

MARCH 29, 2024

In this Pharmaceutical Commerce video interview, Joerg Tritschler, a partner in Simon-Kucher’s life sciences division, discusses the hottest therapeutic settings for dealmaking activity at the moment—and one platform approach in particular poised to be at the center of future M&A and licensing pursuits.

Life Science 52

Life Science Licensing Licensing 52

XTalks

MAY 20, 2022

Depending on the type of field or company, you can pursue clinical scientist jobs with a major in biology, medicine, medical technology, chemistry, immunology and other related life science and pre-medical degrees. In addition, some clinical scientist jobs require you to be licensed or certified.

Scientist 105

Scientist Life Science Clinical Research Doctors 105

The Pharma Data

DECEMBER 20, 2020

Allecra, subject to the satisfaction of terms and conditions as set forth in the Exclusive Licensing Agreement, is to receive an upfront cash payment and is eligible to receive additional development and commercial milestone payments with an overall deal value of $78 million, in addition to royalties.

Licensing 40

Licensing Licensing Life Science Manufacturing 40

Pharmaceutical Technology

JANUARY 25, 2023

Many of those companies were uncharacteristically early in development,” notes Barbara Ryan, senior advisor of Life Sciences at Ernst & Young. This will also make fundraising challenging and adversely impact peoples’ enthusiasm about life science companies, creating a vicious cycle, he adds.

Marketing 173

Marketing Life Science Pharma Companies Licensing 173

pharmaphorum

OCTOBER 3, 2022

It is therefore an interesting development that sugemalimab was given an Innovation Passport in NICE’s Innovative Licensing and Access Pathway (ILAP) in October 2021. About CRA and the Life Sciences Practice. Justus Dehnen is a vice president in the Life Sciences Practice at CRA with more than 20 years in the industry.

Life Science 98

Life Science Marketing Manufacturing Drugs 98

pharmaphorum

NOVEMBER 2, 2020

This followed a separate deal with Sanofi in July, where the pharma licensed Kiadis’ pre-clinical drug K-NK004 for multiple myeloma. Funds managed by Life Sciences Partners have committed to support the offer, accounting for 18.3% of shares in the Netherlands-based biotech.

Life Science 98

Life Science Manufacturing Clinical Trials Clinical Trials 98

The Pharma Data

JUNE 14, 2023

About Bayer Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Cedilla will also be eligible to receive royalties on medicines based on their technology commercialized by Bayer. Financial details have not been disclosed.

Licensing 40

Licensing Licensing Life Science Development 40

pharmaphorum

JUNE 30, 2021

The designation means that LentiGlobin will be reviewed by the Medicines and Healthcare products Regulatory Agency (MHRA) via the new innovative licensing and access pathway (ILAP) introduced last December. ILAP is also a key component part of the UK’s plan to attract life sciences investment following the departure from the EU.

Gene Therapy 98

Gene Therapy Gene Medicine Life Science 98

pharmaphorum

MARCH 9, 2021

Episode 3 of the Alderley Park Discovery Podcast covers how to successfully access life science funding and investment, highlighting a range of ways companies can attract investors.

Life Science 52

Life Science Licensing Licensing Scientist 52

pharmaphorum

AUGUST 19, 2021

The Good Clinical Trials Collaborative (GCTC) has published a draft guidance document, and is asking for the life sciences sector to make its views known. Many guidelines focus narrowly on clinical trials that are intended to generate data for regulatory submission to support a new drug license. Collective action.

Trials 105

Trials Clinical Trials Clinical Trials Life Science 105

XTalks

MARCH 17, 2025

Roche, a global leader in biotechnology and diagnostics, has entered into an exclusive collaboration and licensing agreement with Zealand Pharma, a specialist in innovative therapeutics, to co-develop and co-commercialize petrelintide as a potential foundational therapy for people with overweight and obesity. billion $1.4

Hormones 59

Hormones Drugs Sales Insulin 59

XTalks

MARCH 19, 2025

Beyond eneboparatide, AstraZeneca has continued its M&A activity including the acquisition of Esobiotec towards cell therapy innovation and a licensing agreement with Alteogen for subcutaneous formulations of oncology assets.

Trials 59

Trials Hormones Engineer Licensing 59